| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
DE:AFX
Carl Zeiss Meditec
|
Aug 11, 2026 | SELL |
Sell
+54.0% avg upside
13 analysts
|
$22.60
27.21% Downside
|
· | · |
|
GB:CTEC
ConvaTec
|
Aug 06, 2026 | BUY |
Strong Buy
+26.7% avg upside
18 analysts
|
$375.00
60.05% Upside
|
· | · |
|
DE:FME
Fresenius Medical Care AG & Co. KGaA
|
Aug 04, 2026 | SELL |
Hold
+20.3% avg upside
23 analysts
|
$37.00
11.41% Downside
|
-1.4% | · |
|
DE:SHL
Siemens Healthineers AG
|
Aug 03, 2026 | HOLD |
Buy
+25.1% avg upside
24 analysts
|
$38.00
4.01% Downside
|
+0.3% | · |
|
NL:PHIA
Koninklijke Philips N.V.
|
Aug 03, 2026 | HOLD |
Buy
+29.4% avg upside
21 analysts
|
$24.00
1.89% Upside
|
+0.4% | · |
|
GEHC
GE Healthcare Technologies Inc
|
Jul 31, 2026 | HOLD |
Strong Buy
+13.0% avg upside
22 analysts
|
$73.00
0.03% Upside
|
+6.3% | · |
|
CH:MOVE
Medacta Group SA
|
Jul 21, 2026 | HOLD |
Buy
+1.8% avg upside
5 analysts
|
$148.00
10.92% Upside
|
+0.5% | · |
|
DE:FRE
Fresenius SE & Co. KGaA
|
Jun 03, 2026 | BUY |
Strong Buy
+8.9% avg upside
20 analysts
|
$54.00
14.58% Upside
|
+27.3% | · |
|
SE:EKTA.B
Elekta AB
|
May 21, 2026 | SELL |
Strong Sell
+15.6% avg upside
12 analysts
|
$39.00
25.70% Downside
|
+18.8% | · |
|
GB:0QBO
Coloplast A/S
|
May 21, 2026 | BUY |
Buy
+68.2% avg upside
17 analysts
|
$530.00
23.88% Upside
|
· | · |
|
CH:ALC
Alcon
|
May 21, 2026 | BUY |
Buy
+18.5% avg upside
35 analysts
|
$86.00
40.94% Upside
|
+5.9% | · |
|
AMBFF
Ambu
|
May 21, 2026 | BUY |
Buy
+1.8% avg upside
2 analysts
|
$14.84
36.70% Upside
|
+9.6% | · |
|
DE:OBCK
Ottobock SE & Co. KGaA
|
May 21, 2026 | BUY |
Strong Buy
+43.8% avg upside
4 analysts
|
$74.00
26.30% Upside
|
+1.4% | · |
|
CH:STMN
Straumann Holding AG
|
Apr 30, 2026 | HOLD |
Buy
+21.9% avg upside
15 analysts
|
$90.00
13.76% Downside
|
+20.6% | · |
|
WILLF
Demant
|
Apr 15, 2026 | BUY |
Buy
-5.1% avg upside
19 analysts
|
$37.11
17.40% Downside
|
+40.1% | · |
|
CH:SOON
Sonova Holding AG
|
Mar 24, 2026 | HOLD |
Hold
-6.6% avg upside
18 analysts
|
$215.00
10.02% Downside
|
+21.7% | · |
|
GB:SN
Smith & Nephew
|
Mar 17, 2026 | HOLD |
Buy
+1236.5% avg upside
16 analysts
|
$1300.00
17.30% Upside
|
-12.2% | · |
|
GB:0QIU
Novo Nordisk
|
Jan 25, 2022 | SELL |
Hold
+33.5% avg upside
29 analysts
|
— | · | · |
|
CH:NOVN
Novartis AG
|
Jan 25, 2022 | HOLD |
Buy
-11.3% avg upside
32 analysts
|
— | +10.5% | · |
|
GB:AZN
AstraZeneca
|
May 29, 2020 | BUY |
Strong Buy
+23.4% avg upside
26 analysts
|
— | -7.5% | · |
|
GB:GSK
GlaxoSmithKline
|
May 28, 2020 | HOLD |
Hold
+2.1% avg upside
25 analysts
|
— | -19.5% | · |
|
DE:BAYN
Bayer
|
Jan 22, 2020 | BUY |
Strong Buy
+7.1% avg upside
30 analysts
|
$90.00
83.94% Upside
|
-26.1% | · |
|
CH:ROP
Roche Holding AG
|
Jun 20, 2019 | HOLD |
Buy
-8.6% avg upside
23 analysts
|
$275.00
25.53% Downside
|
+27.8% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.